A positive surprise is on the way: ArriVent BioPharma Inc. (AVBP) Stock
Jefferies raised the price target for the ArriVent BioPharma Inc. (NASDAQ:AVBP) stock to “a Buy”. The rating was released on February 20, 2024, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $30. The latest trade, Performances and Moving Averages give us the following […]
